JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
SUPN - Supernus Pharmaceuticals, Inc.
USD | NASDAQ | Healthcare
Summary
Summary SUPN Stock
Financials
Financials SUPN Stock
Loading...
Loading...
Income Statement
Income Statement SUPN Stock
Balance Sheet
Balance Sheet SUPN Stock
Cash Flow Statement
Cash Flow Statement SUPN Stock
Loading...
Loading...
SUPN Financials - Supernus Pharmaceuticals Income & Cash Flow | Ledgeburg
Home
Stocks
Supernus Pharmaceuticals, Inc. (SUPN)
Financials
Financials of SUPN
Loading...
Loading...
Loading...
Loading...
Revenue
$718.952M
Operating Income
$-62.283M
Net Income
$-38.55M
Share Count (Basic)
56.451136M
Operating Cash Flow
$47.331M
Free Cash Flow
$45.993M
Cash And Short-Term Equivalents
$128.448M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
200M
400M
600M
800M
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
50M
100M
150M
200M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-40M
-20M
0
20M
40M
60M
80M
Annual
Quarterly
Margins
Gross
Operating
Net
0%
20%
40%
60%
80%
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-40M
-20M
0
20M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
0%
50%
100%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26